Lazard Asset Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,331
Closed -$7K 2625
2022
Q1
$7K Sell
1,331
-2,159
-62% -$19.4K ﹤0.01% 2167
2021
Q4
$52K Sell
3,490
-14,510
-81% -$264K ﹤0.01% 1725
2021
Q3
$471K Buy
+18,000
New +$663K ﹤0.01% 1187
2021
Q2
Sell
-44
Closed -$2K 2115
2021
Q1
$2K Sell
44
-6,934
-99% -$331K ﹤0.01% 1817
2020
Q4
$298K Buy
6,978
+6,889
+7,740% +$261K ﹤0.01% 1051
2020
Q3
$3K Buy
+89
New +$4.43K ﹤0.01% 1564

Other funds holding TRHC

Lazard Asset Management's TRHC Position: Q2 2022 in Review

Lazard Asset Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 1,331 shares — an estimated $7K sold.

Lazard Asset Management first reported a position in TRHC in Q3 2020 and held it in 6 quarters. The position peaked at $471K in Q3 2021. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • Lazard Asset Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Lazard Asset Management sold 1,331 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $7K.
  • Lazard Asset Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Lazard Asset Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $471K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.